Patient recruitment has begun in a National Institutes of Health (NIH) trial of two digital therapeutics (DTx) for people with opioid use disorder (OUD), developed by Pear Therapeutics and Chess ...
The global market is witnessing significant expansion, driven by the rising prevalence of opioid use disorder (OUD) and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results